$NVLX According to the American cancer Society, in the US

New Post Public Reply Private Reply Replies (0) Message Board
Tandrel
$NVLX According to the American cancer Society, in the US alone, approximately 45,000 new cases of pancreatic cancer are expected to be diagnosed this year and about 38,000 people are predicted to die from the disease; it is the leading cause of cancer deaths in the US and worldwide. Often pancreatic cancer is not diagnosed until it has reached an advanced stage. By this time, the cancer cannot be removed surgically, is often resistant to radiation therapy or chemotherapy, and has spread (metastasized) to other organs in the body. Because of this, the average survival of patients with advanced, inoperable pancreatic cancer is given in terms of weeks or months, not years.Nuvilex’s pancreatic cancer treatment consists of the use of a proprietary cellulose-based live-cell encapsulation technology together with the long-known and widely used anticancer drug ifosfamide.In a Phase I/II open-label, prospective, single-arm clinical trial, the live-cell encapsulation/ifosfamide combination was used to treat patients with advanced, inoperable pancreatic cancer. Fifty-one patients were originally “screened” for the trial; of these, 17 were enrolled in the study. Other patients were excluded from enrollment for therapy because of previous chemotherapy, previous pancreatic surgery, poor overall health, unwillingness to participate, or death prior to the start of the trial. Of the 17 patients initially enrolled in the study, 14 were ultimately treated. Results obtained in the clinical trial were compared with historical data for gemcitabine and included: median survival time of 44 weeks (after diagnosis) with the cell encapsulation/ifosfamide treatment as compared to 28 weeks with gemcitabine; doubling of the one-year survival rate – 36% with our treatment vs. 18% with gemcitabine; tumor volume was reduced 25-50% in 4 of the 14 treated patients and remained stable in the remaining patients; no serious drug-related side effects with the encapsulated cell/ifosfamide treatment whereas serious and very serious side effects were reported with gemcitabine; the lack of serious side effects using our treatment is probably related to the use of “lower than normal” doses of ifosfamide; limited side effects and reduced cancer pain intensity led to a generally increased ‘quality of life” for the majority of patients. In a “worst case” scenario, some clinical benefit was seen in 50% of patients and in a “best case” scenario, this number increased to 71%; none of the patients who experienced a clinical benefit required and increase in their pain medication.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

APsystems Unveils C&I Storage Solutions at SEF 2026

Updated Category News Views 6

APsystems Puts the Spotlight on Advanced Storage Move over, traditional energy solutions—APsystems is stepping into the future with a bang at the Smart Energy Forum 2026 in Prague. Set your sights on the latest advancements in solar and energy storage solutions as the company unveils its comprehensive offerings. If you’re hanging around the PVA EXPO PRAHA on October...

Continue Reading
Tchah Sup Kim: A Retrospective at KCCNY in 2026

Updated Category News Views 4

A Glimpse into Tchah Sup Kim's Legacy Stumble into the world of Tchah Sup Kim (1940–2022) this fall at the Korean Cultural Center New York. Kim's posthumous retrospective, "The Key to a New World," brings together over 130 of his works alongside archival materials, offering a comprehensive dive into a mind that spent decades between New York and Korea. The exhibit,...

Continue Reading
Jiangxi Dialogues: Youths Forge Global Ties in 2026

Updated Category News Views 6

Bringing Global Youth to the Table In the heart of Jiangxi, China, young minds from across the globe gathered not just to chat but to shape the future. A bunch who only a decade ago might have been ignored in such circles are now leading discussions, and they’ve kicked off their powwow on September 22, 2026, with a bang in Nanchang. What’s the Agenda? Imagine more...

Continue Reading
RingConn Smart Ring Gains Key FDA 510(k) Clearance

Updated Category News Views 9

FDA Clearance: A Major Step for RingConn In a space where every tiny gadget-maker is desperately clawing for a regulatory nod, RingConn—a venture born from Shenzhen Ninenovo Technology Limited—has snagged an FDA 510(k) clearance (Clearance No. K260490) for their wearable Smart Ring that measures blood oxygen levels non-invasively. October 10, 2026, marked the day when...

Continue Reading
New Docs Spotlight Psychiatry on World Mental Health Day

Updated Category News Views 7

Unmasking Mental Health on the Global Stage Hold onto your hats, folks. The Scientology Network is cranking up the heat this World Mental Health Day. On October 10, they’re rolling out a program that puts the spotlight on CCHR’s crusade against what they see as dark forces in the psychiatric industry. It’s a marathon of documentaries that dives into allegations of...

Continue Reading
Young Visionaries Win Junior Medals at STARMUS VIII

Updated Category News Views 8

Fresh from the Canary Islands' shores, STARMUS VIII has lifted the veil on two young powerhouses shaping tomorrow—Valeria Corrales and Aneeshwar Kunchala. These two have snagged coveted honors, crowning them as champions of their generation. Igniting Passion for Science and the Environment Valeria Corrales isn't just another face in the crowd; she’s the force behind a...

Continue Reading
Phoenix Scholar Examines AI and Institutional Trust

Updated Category News Views 5

A Thoughtful Look at Trust and Technology We're staring at an issue here that dives deep into the guts of how technology, AI in particular, is reshaping our professional landscape. The latest issue of the Phoenix Scholar, a publication from the University of Phoenix College of Doctoral Studies, is tackling big questions. It's that kind of brainy reading where you untangle...

Continue Reading
AI in Music: CITY JAM Focuses on Human Creativity

Updated Category News Views 6

Breaking Down the AI Music Race In the wild world of music production, AI's making waves. Here's the thing though—it's all about how fast and how much it can churn out. Now, won't lie to you, that's impressive, but not the full picture. Pat Villaceran, the brain behind CITY JAM, is adamant that the real gold isn't just speed. It's the unique sound each artist brings to...

Continue Reading
Buying Land in Greeneville: Avoiding Costly Mistakes

Updated Category News Views 6

Diving Headfirst into Raw Land Purchases Buying land isn't like your typical house flip in Greeneville, Tennessee. It's a whole different ballgame out there. You might think you're just purchasing a piece of Mother Earth, but you got to know there's more beneath the surface—quite literally—before you sign anything. You can go from a promising adventure to a...

Continue Reading
Retail Trading Platforms Report Record Growth in 2026

Updated Category News Views 4

A Boom in Self-Directed Investing Times are changing, folks. More people than ever are taking finance into their own hands, wielding smartphones like fiscal swords in the name of self-directed investment. No middlemen, no fancy office, just straight-up trading from wherever you might be perched. Four major platforms now boast over 41 million funded accounts combined, each...

Continue Reading

Top 5 Most Recently Viewed Articles

CEO Geoffrey Andrews Announces Retirement and Future Plans

Updated Category News Views 184

CEO Geoffrey Andrews Announces Retirement Recently, Geoffrey Andrews, who has held the position of CEO at the Management Council, declared his plan to retire at the end of this fiscal year. With a remarkable tenure spanning over a decade, he has significantly influenced the organization and the educational landscape in the state. Impact on the Management Council Since...

Continue Reading
Argenta Silver Corp. Partners for Enhanced Marketing Strategies

Updated Category News Views 109

Argenta Silver Corp. Enters a Strategic Marketing Agreement Argenta Silver Corp. (TSXV: AGAG) is making headlines by securing a two-year marketing services agreement with Gold Standard Media, LLC, a prominent player in internet marketing and advertising. This collaboration aims to broaden the company’s visibility and enhance investor awareness through targeted financial...

Continue Reading
Amicus Therapeutics and Teva Pharmaceuticals Reach Settlement

Updated Category News Views 151

Amicus Therapeutics Settles Patent Dispute with Teva Pharmaceuticals Recently, Amicus Therapeutics (NASDAQ: FOLD) announced that it has successfully negotiated a comprehensive License Agreement with Teva Pharmaceuticals Inc. (NYSE: TEVA). This agreement marks a significant resolution to the ongoing patent litigation initiated by Amicus over Teva's attempt to introduce a...

Continue Reading
Aerosol Drug Delivery Devices Market Growth Forecast to 2032

Updated Category News Views 235

Aerosol Drug Delivery Devices Market Growth Prospects The aerosol drug delivery devices market is on the brink of significant expansion, projected to soar from approximately USD 26.40 billion in 2023 to an impressive USD 80.43 billion by 2032. This growth represents a robust compound annual growth rate (CAGR) of 13.19% during the period from 2024 to 2032, largely fueled...

Continue Reading
Dimensional Fund Advisors' Investment Insights on American Axle

Updated Category News Views 115

Understanding Dimensional Fund Advisors and American Axle Dimensional Fund Advisors Ltd. plays a pivotal role in the world of investment management. With a keen focus on empirical research and a commitment to delivering exceptional investment results, they have built a solid reputation over the years. One area that has caught their attention is American Axle &...

Continue Reading